Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 24, 2017
Pharmacy Choice - News - Front Page Healthcare News - May 24, 2017

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

5/24/17 - Advanced Roaming Software from Intelligraphics Helps Critical Wi-Fi Medical Devices Stay Connected
Austin, TX May 24, 2017 May 24, 2017. Patient Monitoring and Diagnostic Systems Require Constant Connectivity. Medical systems are increasingly being developed with Wi-Fi connectivity to reduce the amount of wiring in a healthcare facility and allow them to be easily moved from room to room.
5/24/17 - Agilis Biotherapeutics Announces Presentation of Data from Phase I/II Trial for Treatment of AADC Deficiency
The gene therapy treatment candidate, AGIL-AADC, is an adeno-associated virus vector containing the human gene for the AADC enzyme. Dr. Hwu stated, "We are pleased to present this important work highlighting the encouraging safety and efficacy observed to date in which AADC deficiency patients treated with the AGIL-AADC gene therapy have exhibited.
5/24/17 - AHCA Threatens Ohio's Growing Health Care Sector
If the AHCA becomes law, places like the Premier Atrium Medical Center in Middletown could face massive cuts. "Premier Health stands to lose $861.1 million in Medicaid cuts through 2026 and see a $182 million increase in costs for treating people who are uninsured," said Mike Uhl, President of Premier Atrium Medicaid Center. "Combined, these pote
5/24/17 - ALUNBRIGTM brigatinib Approved for the Treatment of ALK+ Metastatic Non-Small Cell Lung Cancer, Available for Order at Biologics, Inc.
By a News Reporter-Staff News Editor at Biotech Week Biologics, Inc., a McKesson Specialty Health oncology pharmacy services company, has been selected by Takeda Pharmaceutical Company Limited, through its wholly-owned subsidiary ARIAD Pharmaceuticals, Inc., to be a specialty pharmacy provider as part of the distribution network for ALUNBRIGTM.
5/24/17 - ASH President Responds to President Trump's Proposal to Cut One in Five Dollars to NIH, Public Health Programs
American Society of Hematology President Kenneth C. Anderson, MD, of the Dana-Farber Cancer Institute, responded to the White House's fiscal year 2018 budget request, which proposes a $7.18 billion cut to the National Institutes of Health, 21 percent of the FY17 allocation:. The Administration's proposed cut of one in every five dollars to this vit
5/24/17 - AZs Bydureon disappoints in diabetes outcomes trial [Sudan Tribune]
The FDA now obliges companies with diabetes products to conduct large scale cardiovascular outcomes trials, and the once weekly GLP-1 drug Bydureon was studied for its effects on a composite measure of major adverse CV events. Novo Nordisks rival GLP-1 treatment Victoza is close behind, and is expected to gain FDA approval for similar claims this y
5/24/17 - Bharat Book Bureau: Global MRI Market by Manufacturers
MRI is diagnostic equipment that uses a magnetic field and radio waves to create detailed images of the organs and tissues within your body. This report focuses on the MRI in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions,
5/24/17 - Bill would ease action on insurance market upheaval
Facing a repeal of the Affordable Care Act and potential premium hikes next year, New Hampshire lawmakers are proposing to give state regulators broad authority to quickly respond. The Senate Health and Human Services Committee endorsed the amendment unanimously Tuesday, saying the state should be able to act fast should anything happen.
5/24/17 - Biogen buys Remedy Pharmaceuticals` stroke drug Cirara [Syrian Arab News Agency]
Biogen last week completed an asset purchase of Remedy Pharmaceuticals phase 3 candidate, Cirara. The US Food and Drug Administration recently granted Cirara Orphan Drug Designation for severe cerebral edema in patients with acute ischemic stroke. Each year approximately 1.7 million ischemic strokes occur across the US, Europe and Japan, and...
5/24/17 - Bioverativ to Acquire Clinical-Stage Rare Disease Biotechnology Company, True North Therapeutics [Algeria Press Service]
Bioverativ Inc., a global biotechnology company focused on the discovery, development and commercialization of innovative therapies for hemophilia and other rare blood disorders, today announced that it has entered into a definitive agreement to acquire South San Francisco-based True North Therapeutics, a privately-held, clinical-stage rare disease
5/24/17 - California takes wait-and-see approach to Trump's proposed Medicaid cuts
While President Trump's proposed budget would mean a big hit to Medi-Cal, California is opting for a wait-and-see approach to let the political debate in Washington run its course. About one-third of Californians are on Medi-Cal, the state's version of Medicaid, the health insurance program for certain low-income Americans. "We don't want to have
5/24/17 - Cancer survivor worried about what could happen if Trumpcare approved
He is passionately concerned about the implications of the American Health Care Act and Republican efforts to slash the health safety net, including $800 billion in proposed cuts over 10 years from Medicaid. Brian Mast, R-Palm City, who voted twice for the AHCA. Weiss wrote an angry letter after my column about the AHCA's implications for mental he
5/24/17 - ClearHealth Quality Institute Seeks Board of Directors and Standards Committee Volunteers
In May, the American Telemedicine Association and CHQI launched a joint venture to develop the next generation of telemedicine standards. Jonathon Linkous, CEO of the American Telemedicine Association said, "The joint venture with CHQI and the expansion of the online patient consultation program ensures increased accountability, integrity and
5/24/17 - Connected Medical Devices Market witnessed continued demand during forecast 2027
Key Players: A&D Medical, Aerotel, Animas Corporation, BL Healthcare, Body Media Inc., Boston Scientific, DexCom Inc., Docobo, eHIT Ltd, eDevice, " Market Research Future PUNE, MAHARASHTRA, INDIA, May 24, 2017/ EINPresswire.com/ Market Scenario: Connected medical devices are majorly used for the connected health solutions that replace the tradi
5/24/17 - Credence Research: Global Disposable Medical Device Sensors Market is expected to grow at the CAGR of 11% during 2015-2022
According to a recently published report, Global Disposable Medical Device Sensors Market is expected to grow at the CAGR of 11% during 2015-2022 and it estimated to be $7.5 billion by 2022. Global Disposable Medical Device Sensors Market is expected to contribute highest in North America followed by Europe. Medtronic PLC., GE Healthcare, Philips N
5/24/17 - Curetis Provides Business and Financial Update for the First Quarter 2017
Recent Operational and Business Highlights Unyvero U.S. FDA Trials* In January 2017, Curetis filed a 510 application with the U.S. Food and Drug Administration to obtain clearance for its Unyvero Platform and LRT Application Cartridge. The submission is based on clinical data from the Company's U.S. FDA trial comparing the performance of the Unyver
5/24/17 - Curetis Provides Update on Unyvero LRT FDA 510(k) Submission
Curetis Provides Update on Unyvero LRT FDA 510 Submission- Curetis reiterates that it expects FDA to provide decision on clearance of Unyvero LRT in the second half of 2017 Amsterdam, the Netherlands, and Holzgerlingen, Germany, May 24, 2017- Curetis N.V., a developer of next-level molecular diagnostic solutions, today provided an update regarding
5/24/17 - Cytori Logs Final 48 Week Patient Follow Up Visit in Scleroderma Trial [Sudan Tribune]
-Cytori Therapeutics, Inc., today announced that it has now completed all 48 week follow up monitoring visits in its U.S. FDA approved Phase III STAR trial. A total of 88 subjects were enrolled and the last subjects 48 week visit was conducted earlier this week. In the United States, the scleroderma affected population appears to be approximately 1
5/24/17 - Debiopharm International SA Enters the Field of Antibody-Drug Conjugates Through Acquisition of Phase II Asset From ImmunoGen
Transaction a dds i nnovative c linical- s tage p rogram to e xpanding Debiopharm p ortfolio and broadens its clinical development expertise. Debiopharm International SA, part of Debiopharm Group?, a Switzerland- based biopharmaceutical company, and ImmunoGen, Inc., a leader in the expanding field of antibody-drug conjugates for the treatment of
5/24/17 - Diplomat Acquires WRB Communications
By a News Reporter-Staff News Editor at Biotech Week Diplomat Pharmacy, Inc.., has completed its acquisition of WRB Communications, Inc., a health care service center company based in Chantilly, Virginia. WRB will join Envoy Health Management, LLC, as part of Diplomat's commercialization support services for manufacturers, biotech firms, and othe
5/24/17 - FDA Approves First Cancer Treatment for Any Solid Tumor with a Specific Genetic Feature
The U.S. Department of Health and Human Services' Food and Drug Administration issued the following news release:. "This is an important first for the cancer community," said Richard Pazdur, M.D., acting director of the Office of Hematology and Oncology Products in the FDA's Center for Drug Evaluation and Research and director of the FDA's Oncolog
5/24/17 - FDA approves Merck's bladder cancer drug
The FDA has approved two new indications for Merck's Keytruda (pembrolizumab), the company's anti-PD-1 therapy, for bladder cancer...
5/24/17 - FDA approves Roche's Actemra/RoActemra (tocilizumab) for giant cell arteritis
-Actemra/RoActemra is the first FDA- approved treatment for adults with giant cell arteritis. -FDA previously granted Priority Review and Breakthrough Therapy Designation for Actemra/RoActemra in GCA. "Today's FDA decision means people living with giant cell arteritis will, for the first time, have an FDA- approved treatment option for this debili
5/24/17 - Franciscans Fight Back Against Immoral, Destructive Budget Proposal
Today, President Donald Trump released the full budget proposal which contains detailed information about major cuts to Medicaid, as well as a call for changes to anti-poverty programs that will limit assistance to populations in need. Despite promises that everyone will still have access to healthcare, the President is proposing massive cuts to Me
5/24/17 - Generational Equity Announces Sale of Safis Solutions to PharmaLex Group
By a News Reporter-Staff News Editor at Biotech Week Generational Equity, a leading mergers and acquisitions advisor for privately held businesses, is pleased to announce the sale of its client, Safis Solutions LLC, to the PharmaLex Group. Safis Solutions, headquartered in Indianapolis, Indiana, assists pharmaceutical, medical device and biotech
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415